Table 1.
Baseline clinical characteristics
| Group I (n=77) ReoPro®-coated stent | Group II (n=78) Control stent | p | |
|---|---|---|---|
| Age (years) | 56.0±10.0 | 56.9±10.5 | 0.584 |
| Male (%) | 64 (83.1) | 53 (67.9) | 0.039 |
| Risk factor (%) | |||
| Current smoking | 45 (58.4) | 42 (53.8) | 0.628 |
| Hypertension | 37 (48.1) | 40 (51.3) | 0.749 |
| Hypercholesterolemia | 28 (36.4) | 26 (33.3) | 0.738 |
| Diabetes mellitus | 18 (23.4) | 12 (15.4) | 0.228 |
| Clinical Diagnosis (%) | 0.746 | ||
| Stable angina | 7 (9.1) | 7 (9.0) | |
| Unstable angina | 39 (50.6) | 39 (50.0) | |
| Non-ST elevation MI | 9 (11.7) | 7 (9.0) | |
| ST elevation MI | 20 (26.0) | 22 (28.2) | |
| Old myocardial infarction | 2 (2.6) | 3 (3.8) | |
| Combined vascular disease (%) | |||
| Peripheral | 1 (1.3) | 1 (1.3) | 1.00 |
| Hemorrhagic stroke | 0 (0.0) | 0 (0.0) | 1.00 |
| Transient ischemic attack | 2 (2.6) | 5 (6.4) | 0.189 |
| Family history | 3 (3.9) | 3 (3.8) | 1.00 |
| Previous coronary procedure (%) | |||
| Percutaneous coronary intervention | 4 (5.2) | 5 (6.4) | 1.00 |
| Bypass surgery | 0 (0.0) | 0 (0.0) | 1.00 |
| Left ventricular function (%) | |||
| Mean ejection fraction | 62.8±10.1 | 62.8±12.0 | 0.994 |
MI, myocardial infarction